IP Verse

Stents, Valved-Stents And Methods And Systems For Delivery Thereof

Patent No. EP3311779 (titled "Stents, Valved-Stents And Methods And Systems For Delivery Thereof") was filed by Boston Scientific on Oct 27, 2008. The application was issued on Apr 24, 2024.

Patent Summary

A minimally invasive cardiac valve replacement system that enables replacement of heart valves without open-chest surgery or cardiopulmonary bypass. The system includes a valved-stent that combines a stent and a biological or synthetic valve, and a delivery system that allows controlled deployment of the valved-stent through a small incision in the chest. The valved-stent is designed to expand and stabilize in place, with features such as a double PET fabric skirt to prevent injury to surrounding tissues. The delivery system includes a sheath that constrains the valved-stent during deployment, allowing for precise control over the expansion process.

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
EDWARDS LIFESCIENCESJan 24, 2025SOMERVILLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3311779

BOSTON SCIENTIFIC
Application Number
EP17206130A
Filing Date
Oct 27, 2008
Status
Granted And Under Opposition
Mar 22, 2024
Publication Date
Apr 24, 2024
External Links
Slate, Register , Google Patents